Sergio Ermotti, CEO of Swiss banking giant UBS, during the group’s annual shareholders meeting in Zurich on May 2, 2013.
Fabrice Coffrini | Afp | Getty Images
Switzerland’s tough new banking regulations create a “lose-lose situation” for UBS and may limit its potential to challenge Wall Street giants, according to Beat Wittmann, partner at Zurich-based Porta Advisors.
In a 209-page plan published Wednesday, the Swiss government proposed 22 measures aimed at tightening its policing of banks deemed “too big to fail,” a year after authorities were forced to broker the emergency rescue of Credit Suisse by UBS.
The government-backed takeover was the biggest merger of two systemically important banks since the Global Financial Crisis.
At $1.7 trillion, the UBS balance sheet is now double the country’s annual GDP, prompting enhanced scrutiny of the protections surrounding the Swiss banking sector and the broader economy in the wake of the Credit Suisse collapse.
Speaking to CNBC’s “Squawk Box Europe” on Thursday, Wittmann said that the fall of Credit Suisse was “an entirely self-inflicted and predictable failure of government policy, central bank, regulator, and above all [of the] finance minister.”
“Then of course Credit Suisse had a failed, unsustainable business model and an incompetent leadership, and it was all indicated by an ever-falling share price and by the credit spreads throughout [20]22, [which was] completely ignored because there is no institutionalized know-how at the policymaker levels, really, to watch capital markets, which is essential in the case of the banking sector,” he added.
The Wednesday report floated giving additional powers to the Swiss Financial Market Supervisory Authority, applying capital surcharges and fortifying the financial position of subsidiaries — but stopped short of recommending a “blanket increase” in capital requirements.
Wittman suggested the report does nothing to assuage concerns about the ability of politicians and regulators to oversee banks while ensuring their global competitiveness, saying it “creates a lose-lose situation for Switzerland as a financial center and for UBS not to be able to develop its potential.”
He argued that regulatory reform should be prioritized over tightening the screws on the country’s largest banks, if UBS is to capitalize on its newfound scale and finally challenge the likes of Goldman Sachs, JPMorgan, Citigroup and Morgan Stanley — which have similarly sized balance sheets, but trade at s much higher valuation.
“It comes down to the regulatory level playing field. It’s about competences of course and then about the incentives and the regulatory framework, and the regulatory framework like capital requirements is a global level exercise,” Wittmann said.
“It cannot be that Switzerland or any other jurisdiction is imposing very, very different rules and levels there — that doesn’t make any sense, then you cannot really compete.”
In order for UBS to optimize its potential, Wittmann argued that the Swiss regulatory regime should come into line with that in Frankfurt, London and New York, but said that the Wednesday report showed “no will to engage in any relevant reforms” that would protect the Swiss economy and taxpayers, but enable UBS to “catch up to global players and U.S. valuations.”
“The track record of the policymakers in Switzerland is that we had three global systemically relevant banks, and we have now one left, and these cases were the direct result of insufficient regulation and the enforcement of the regulation,” he said.
“FINMA had all the legal backdrop, the instruments in place to address the situation but they didn’t apply it — that’s the point — and now we talk about fines, and that sounds like pennywise and pound foolish to me.”
Check out the companies making headlines in midday trading. Global pharma stocks — Shares of several vaccine makers declined after President-elect Donald Trump selected prominent vaccine skeptic Robert F. Kennedy Jr. as health secretary on Thursday. Shares of Moderna and Pfizer slipped nearly 9% and 5%, respectively. BioNTech , which helped develop a Covid vaccine with Pfizer, shed 5%, while GSK declined about 2%. Even names such as Eli Lilly and Novo Nordisk were lower, with both stocks slipping about 4%, amid concerns that the drug approval process could be slowed. Super Micro Computer — Shares of the embattled server company fell 2% ahead of a Monday deadline that could result in the company being delisted from the Nasdaq. Super Micro is late on filing a year-end report with the Securities and Exchange Commission, putting it on the wrong side of the Nasdaq’s rules. This would be the 11th losing day in the last 13 trading sessions for Super Micro. Alibaba — S hares slipped more than 2% after the Chinese e-commerce giant’s fiscal second-quarter sales fell short of estimates amid a weakening consumer backdrop in China. Alibaba’s revenue of 236.5 billion yuan came out 5% higher year on year but below analysts’ expectations of 238.9 billion yuan, per LSEG. Palantir — Shares jumped 7% after the analytics software provider said it is moving its listing to the Nasdaq Global Select Market from the New York Stock Exchange. Palantir expects to be eligible to join the Nasdaq-100 Index once it makes the switch. Domino’s Pizza , Pool Corp. , Ulta Beauty — Shares of the pizza chain edged up 0.3% after Warren Buffett ‘s Berkshire Hathaway announced a new stake in Domino’s, while Pool Corp. gained almost 2% as the conglomerate purchased a small stake in the swimming pool supplier. Ulta slipped nearly 3% after Berkshire Hathaway revealed in a regulatory filing that it had sold around 97% of its shares, nearly dissolving its position in the beauty retailer. Berkshire had just bought the stock in the second quarter, making Ulta a relatively new bet. AST SpaceMobile – Shares plunged more than 11% on the heels of the company’s weaker-than-expected third-quarter results. AST SpaceMobile reported a loss of $1.10 per share on revenue of $1.1 million. That’s well below the loss of 20 cents per share and $1.8 million in revenue that analysts were expecting, according to FactSet. Applied Materials — The semiconductor equipment manufacturer dropped 8% after providing a softer-than-forecast revenue outlook for the current quarter. Applied Materials told investors to expect $7.15 billion in the first fiscal quarter, less than the estimate of $7.22 billion from analysts polled by LSEG. However, the company beat expectations on both lines in the fourth fiscal quarter and issued positive guidance for adjusted earnings per share. — CNBC’s Sean Conlon, Alex Harring, Jesse Pound, Hakyung Kim and Lisa Han contributed reporting.
Billionaire investor Ron Baron, a longtime Tesla bull and shareholder, believes the electric vehicle company could hit a $5 trillion market capitalization in a decade, saying CEO Elon Musk has an even higher number in mind longer term. “Tesla, I think, is going to be worth $3 or $4 trillion — $5 trillion in 10 years, based upon the business plan that I am aware of. Then Elon believes that longer term it’s going to be worth $30 trillion,” Baron said on CNBC’s ” Squawk Box ” Friday. At $3.65 trillion, Nvidia had the largest market value in the U.S. as of Thursday’s market close, bigger than Apple and Microsoft , according to FactSet data. Tesla closed Thursday with a market cap of $1.12 trillion. Baron first invested $400 million in Tesla between 2014 and 2016, and said the early bet has made him $6 billion so far as the EV company gained mainstream acceptance. Tesla represents 10% of Baron’s entire portfolio across different funds. TSLA ALL mountain Tesla Tesla is seen as a big beneficiary of promised Trump administration policies as Musk has this year been a prominent backer and donor to the president-elect. Musk recently got assigned a starring role by Trump, leading the so-called Department of Government Efficiency , along with Vivek Ramaswamy, former Republican presidential candidate. Shares of Tesla have surged about 25% in November alone during the postelection rally to return to a $1 trillion market cap. Baron said he will hold onto his Tesla shares for the long run. “No way I’m going to sell shares. If they get too big I will have to trim a little bit, but no I have no intention” of exiting, he said. The Baron Capital chair has also built his bullish case for Tesla on the prospect for its Optimus humanoid robot now in development. Last month at a ‘ We, Robot ‘ event, Musk said Tesla has made progress on Optimus and that it will eventually cost between $20,000 and $30,000, adding it will “be a teacher, babysit your kids, walk your dog, mow your lawn, get the groceries … Whatever you can think of it will do.” “The idea is that these robots … he thinks it will be his biggest business ever,” Baron said. “He says everyone will have robots.”
Check out the companies making headlines before the bell. Applied Materials — Shares tumbled more than 8% after the semiconductor equipment manufacturer offered weak revenue guidance for the current quarter. Applied Materials said it forecasts $7.15 billion in the first fiscal quarter, under the estimate of $7.224 billion from analysts polled by LSEG. The company also reported better-than-expected fiscal fourth-quarter results and provided a strong outlook for adjusted earnings per share. Alibaba — S hares jumped more than 3% after the Chinese e-commerce giant beat profit expectations in its fiscal second quarter , although its sales disappointed as the company continues to grapple with weaker consumer spending in China. Alibaba’s net income rose 58% year-on-year, on the back of its equity investment performance. Its revenue of 236.5 billion yuan came out 5% higher year-on-year but below analysts’ expectations of 238.9 billion yuan, according to LSEG data. Moderna — The biotech company’s shares fell 1.8%, continuing its decline from Thursday following the news that Robert F. Kennedy Jr., a prominent vaccine skeptic, was announced as President-elect Donald Trump’s nominee for secretary of the Department of Health and Human Services. Domino’s Pizza , Pool Corp. — Shares of the pizza chain jumped about 6% after Warren Buffett ‘s Berkshire Hathaway announced a new stake in Domino’s in a regulatory filing. Berkshire Hathaway bought more than 1.2 million shares, making the investment worth around $550 million at the end of September. Pool Corp. also gained 6% as the conglomerate purchased around 404,000 shares of the swimming pool supplier, worth $152 million at the end of the period. Ulta Beauty – Shares slipped 5% after Berkshire Hathaway revealed in a regulatory filing that it had nearly dissolved its position in the beauty retailer, selling around 97% of its shares. Ulta was a new bet for Berkshire, which had just bought the stock in the second quarter. Palantir — The defense tech stock rose more than 2% after saying it was moving its listing to the Nasdaq Global Select Market from the New York Stock Exchange. The company said it expects to be eligible to join the Nasdaq-100 Index once it makes the switch. — CNBC’s Jesse Pound, Lisa Kailai Han and Pia Singh contributed reporting